AI takes on MS: new study aims to personalize treatment
NCT ID NCT07280871
First seen Jan 07, 2026 · Last updated Apr 23, 2026 · Updated 17 times
Summary
This study will collect health data from 100 people with multiple sclerosis (MS) to find patterns that predict how the disease will progress. Researchers will use artificial intelligence to analyze this information, with the goal of helping doctors choose the best treatment for each patient. The study does not test a new drug but focuses on improving understanding of MS to guide personalized care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de Luxembourg
Luxembourg, L-1210, Luxembourg
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.